KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Inventory (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Inventory for 16 consecutive years, with $30.2 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 3.94% to $30.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.2 million through Dec 2025, up 3.94% year-over-year, with the annual reading at $30.2 million for FY2025, 3.94% up from the prior year.
  • Inventory for Q4 2025 was $30.2 million at Biolife Solutions, up from $27.8 million in the prior quarter.
  • The five-year high for Inventory was $43.4 million in Q1 2024, with the low at $11.7 million in Q1 2021.
  • Average Inventory over 5 years is $31.5 million, with a median of $30.2 million recorded in 2022.
  • The sharpest move saw Inventory skyrocketed 169.06% in 2021, then crashed 36.5% in 2025.
  • Over 5 years, Inventory stood at $28.3 million in 2021, then increased by 23.14% to $34.9 million in 2022, then fell by 22.18% to $27.2 million in 2023, then increased by 6.81% to $29.0 million in 2024, then rose by 3.94% to $30.2 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $30.2 million, $27.8 million, and $27.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.